These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154). Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613 [TBL] [Abstract][Full Text] [Related]
25. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer]. Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082 [TBL] [Abstract][Full Text] [Related]
26. [Blood prolactin level of breast and endometrial cancer patients during surgical intervention]. Pozdniakov VV; Bobrov IuF; Gamaiunova VB; Evtiukhin AI; Frid IA Vopr Onkol; 1984; 30(2):9-14. PubMed ID: 6702135 [TBL] [Abstract][Full Text] [Related]
27. Serum hormones in human breast cancer subjects. Krishnamoorthy G; Govindarajulu P; Ramalingam V Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392 [TBL] [Abstract][Full Text] [Related]
28. [Prolactin and human cancer of the breast. I. Levels of correlation]. Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536 [TBL] [Abstract][Full Text] [Related]
29. Studies on human alpha-lactalbumin: radioimmunoassay measurements in normal human breast and breast cancer. Kleinberg DL; Todd J; Groves ML J Clin Endocrinol Metab; 1977 Dec; 45(6):1238-50. PubMed ID: 22554 [TBL] [Abstract][Full Text] [Related]
30. Letter: Plasma-prolactin in breast cancer. Rolandi E; Barreca T; Masturzo P; Polleri A; Indiveri F; Barabino A Lancet; 1974 Oct; 2(7884):845-6. PubMed ID: 4138369 [No Abstract] [Full Text] [Related]
32. Plasma-prolactin in human breast cancer. Kwa HG; De Jong-Bakker M; Engelsman E; Cleton FJ Lancet; 1974 Mar; 1(7855):433-5. PubMed ID: 4131433 [No Abstract] [Full Text] [Related]
33. Plasma prolactin and breast cancer. Wilson RG; Buchan R; Roberts MM; Forrest AP; Boyns AR; Cole EN; Griffiths K Cancer; 1974 May; 33(5):1325-7. PubMed ID: 4823482 [No Abstract] [Full Text] [Related]
34. Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease. Skinner LG; England PC; Cottrell KM; Selwood RA Br J Cancer; 1974 Aug; 30(2):176-7. PubMed ID: 4419442 [No Abstract] [Full Text] [Related]
35. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma]. Pavić S; Pavić Z Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335 [TBL] [Abstract][Full Text] [Related]
36. Diet, serum, breast fluid growth hormone, and prolactin levels in normal premenopausal Finnish and American women. Rose DP; Boyar AP; Kettunen K Nutr Cancer; 1988; 11(3):179-87. PubMed ID: 2841652 [TBL] [Abstract][Full Text] [Related]
37. [Study of blood copper and iron in women with benign or malignant breast diseases]. Le Borgne de Kaouel C; Aubert C; Juret P Pathol Biol; 1968 Jan; 16(1):85-6. PubMed ID: 4869424 [No Abstract] [Full Text] [Related]
38. Plasma estrogens in childhood and puberty under physiologic and pathologic conditions. Bidlingmaier F; Wagner-Barnack M; Butenandt O; Knorr D Pediatr Res; 1973 Nov; 7(11):901-7. PubMed ID: 4795966 [No Abstract] [Full Text] [Related]
39. Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients. Haagensen DE; Mazoujian G; Holder WD; Kister SJ; Wells SA Ann Surg; 1977 Mar; 185(3):279-85. PubMed ID: 843124 [TBL] [Abstract][Full Text] [Related]
40. [The determination of beta-casein gene expression and the assessment of hormonal homeostasis in gynecomastia patients and in breast cancer in men]. Ganina KP; Liubimova IuIu; Tarutinov VI; Topchiĭ VB; Fedorova LV Vopr Onkol; 1992; 38(6):694-9. PubMed ID: 1300768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]